New drug trial aims to control teen brain tumors while monitoring growth
NCT ID NCT07286292
Summary
This study is testing a drug called vorasidenib in teenagers (ages 12 to under 18) who have a specific type of slow-growing brain tumor. The main goals are to see if the drug is safe, what side effects it causes, and how it might affect the teens' normal growth and development during puberty. Researchers will also track if the drug helps control the tumor.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRADE 2 ASTROCYTOMA OR OLIGODENDROGLIOMA WITH AN IDH1 OR IDH2 MUTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.